Which are the symptoms of Chorea-acanthocytosis ChAc?

Chorea-acanthocytosis (ChAc) is a rare, progressive neurodegenerative disorder characterized primarily by involuntary movements (chorea), oromandibular dystonia, and the presence of spiked red blood cells called acanthocytes. Symptoms typically emerge between the ages of 20 and 40, leading to significant challenges in motor control, speech, and daily functioning.

What are the primary symptoms of Chorea-acanthocytosis?

The clinical presentation of Chorea-acanthocytosis (ChAc) is complex. The most characteristic symptoms involve movement disorders, such as chorea (jerky, involuntary movements) and severe oromandibular dystonia, which often causes patients to bite their own lips, tongue, and inner cheeks. Other core features include:

• Movement disorders: Chorea, tics, and parkinsonism.


• Oral manifestations: Severe tongue and lip biting due to involuntary jaw movements.


• Neuromuscular issues: Muscle weakness, atrophy, and gait instability.


• Cognitive and psychiatric changes: Executive dysfunction and behavioral personality changes.


• Hematological findings: Acanthocytosis, found in approximately 60-90% of patients.

How does Chorea-acanthocytosis progress over time?

Chorea-acanthocytosis (ChAc) is a progressive condition. Early warning signs often include subtle personality shifts or minor difficulties with speech and swallowing. Over time, the involuntary movements often decrease while rigidity and muscle weakness become more prominent. The disease significantly impacts quality of life through dysphagia (difficulty swallowing) and recurrent aspiration, which requires careful management by a multidisciplinary team.

When should you seek immediate medical attention?

Patients living with Chorea-acanthocytosis (ChAc) should seek urgent care if they experience acute respiratory distress due to swallowing difficulties, severe self-inflicted oral trauma that does not stop bleeding, or sudden, unexplained falls that result in injury. Because Chorea-acanthocytosis (ChAc) affects the central nervous system, any rapid decline in cognitive function or consciousness also warrants an immediate neurological evaluation.

Next steps

• Consult a movement disorder specialist or a neurologist familiar with neuroacanthocytosis syndromes.


• Connect with the 6 members of the Chorea-acanthocytosis (ChAc) community on DiseaseMaps.org to share experiences.


• Request a referral to a speech-language pathologist for swallowing safety assessments.


• Discuss genetic testing for the VPS13A gene with a certified genetic counselor.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Chorea-acanthocytosis.


• Orphanet: Chorea-acanthocytosis (ORPHA:167).


• OMIM (Online Mendelian Inheritance in Man): #200150 (Chorea-acanthocytosis).


• The Advocacy for Neuroacanthocytosis Patients (NA Patients).